<DOC>
	<DOCNO>NCT00327418</DOCNO>
	<brief_summary>A study assess efficacy daily atorvastatin 10 mg versus placebo cardiovascular endpoint patient non-insulin-dependent diabetes mellitus ( NIDDM ) history either hypertension , retinopathy , microalbuminuria , macroalbuminuria , currently smoke , establish corornary heart disease macrovascular disease .</brief_summary>
	<brief_title>CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients must document history least one following : Hypertension ( define systolic blood pressure 140 mmHg diastolic blood pressure 90 mmHg ( define disapperance sound [ Korotkoff Phase V ] receive antihypertensive treatment . Blood pressure measure sit patient quietly 3 minute ) . Retinopathy ( define follow ; nonproliferative retinopathy , prepreproliferative retinopathy , proliferative retinopathy , maculopathy , advance diabetic eye disease history photocoagulation ) . Microalbuminuria ( define either , Albumin creatinine ratio &gt; = 2.5 mg/mmol , Albumin excretion rate time collection &gt; = 20 mcg/min ( &gt; = 30 mg/24hrs ) two successive occasion , positive micral strip test ) . Macroalbuminuria ( define either ; Albustix dipstick evidence gross proteinuria , Albumin creatinine ratio &gt; = 25 mg/mmol ; Albumin excretion rate time collection &gt; = 200 mcg/min ( &gt; = 300 mg/24hrs ) two sucessive occasion ) . Current smoker Type I Diabetes Mellitus Any major Coronary event prior entry study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>